To include your compound in the COVID-19 Resource Center, submit it here.

Neotrofin leteprinim (AIT-082): Began Phase II study

NeoTherapeutics Inc. (NEOT), Irvine, Calif.
Product: Neotrofin

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE